Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, New Jersey
- Most recent report
- 8-K, filed Feb 13, 2024
- Filings on record
- 170 filings
- On EDGAR
- CIK 1831283
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 10
News 8 of 29
Prospectuses and Registrations 8 of 18
- S-8 POS Post-effective amendment to an employee plan registration Mar 12, 2024
- S-8 POS Post-effective amendment to an employee plan registration Mar 12, 2024
- S-8 POS Post-effective amendment to an employee plan registration Mar 12, 2024
- POS AM Post-effective amendment to a registration Mar 12, 2024
- 25 Mar 11, 2024
- S-3/A Shelf registration statement, amended Apr 26, 2023
- S-3/A Shelf registration statement, amended Mar 29, 2023
- S-8 Registration statement for an employee plan Mar 28, 2023
Proxies 6
Ownership 8 of 68
- SC 13G Large holder reported a passive stake Nov 14, 2024
- 4 Insider reported a trade Apr 11, 2024
- SC 13D/A Large holder reported an active stake, amended Feb 29, 2024
- 4 Insider reported a trade Feb 20, 2024
- 4 Insider reported a trade Feb 20, 2024
- 4 Insider reported a trade Feb 20, 2024
- 4 Insider reported a trade Feb 20, 2024
- 4 Insider reported a trade Feb 20, 2024
Other 8 of 39
- 15-12G Mar 21, 2024
- EFFECT Notice that a registration became effective Mar 12, 2024
- F-6 POS Mar 12, 2024
- UPLOAD Comment letter from SEC staff Jul 24, 2023
- CORRESP Reply to SEC staff Jul 20, 2023
- UPLOAD Comment letter from SEC staff Jul 10, 2023
- EFFECT Notice that a registration became effective Apr 27, 2023
- CORRESP Reply to SEC staff Apr 26, 2023
Everything here comes from LianBio's own filings on SEC EDGAR. The filing list is rechecked every hour.